COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
Année de publication: 2020
The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources.
Rheumatic Diseases/immunology, Bone Marrow Failure Disorders/diagnosis, Bone Marrow Failure Disorders/complications, Bone Marrow Failure Disorders/drug therapy, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Betacoronavirus, Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control